![John Moriarty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Moriarty
Direttore/Membro del Consiglio presso
American Kidney Fund, Inc.
Patrimonio netto: 994 863 $ in data 31/07/2026
Profilo
John B. Moriarty is Secretary & Trustee at American Kidney Fund, Inc. since 2015 and Secretary & Chief Legal Officer at Kardigan, Inc. starting in 2026.
Former roles include Executive Director & Senior Counsel at Amgen, Inc. from 2002 to 2008; Chief Legal Officer & General Counsel at Elan Corp.
Plc from 2008 to 2012; Executive Vice President & General Counsel at Alexion Pharmaceuticals, Inc. from 2014 to 2018; Secretary, Executive VP & General Counsel at Portola Pharmaceuticals LLC from 2018 to 2020; Senior Vice President & General Counsel at Elan Pharmaceuticals LLC; Secretary, Chief Legal Officer & Executive VP at Olema Pharmaceuticals, Inc. from 2020 to 2023; Secretary, Chief Legal Officer & Executive VP at Mirati Therapeutics, Inc. from 2023 to 2024; and Secretary & Chief Legal Officer at Avidity Biosciences, Inc. from 2024 to 2026.
Education includes undergraduate studies at the University of Virginia and graduate studies at the University of Georgia School of Law.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,05% | 17/06/2026 | 47.784 ( 0,05% ) | 994 863 $ | 31/07/2026 |
Posizioni attive di John Moriarty
| Società | Posizione | Inizio |
|---|---|---|
American Kidney Fund, Inc.
 American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services Provides treatment & financial assistance to kidney patients | Direttore/Membro del Consiglio | 01/01/2015 |
Precedenti posizioni note di John Moriarty
| Società | Posizione | Fine |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Consigliere Generale | 27/02/2026 |
| MIRATI THERAPEUTICS | Consigliere Generale | 23/01/2024 |
| OLEMA PHARMACEUTICALS, INC. | Consigliere Generale | 01/05/2023 |
| PORTOLA PHARMACEUTICALS, INC. | Consigliere Generale | 01/07/2020 |
| ALEXION PHARMACEUTICALS, INC. | Consigliere Generale | 01/02/2018 |
Formazione di John Moriarty
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
86
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
American Kidney Fund, Inc.
American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services Provides treatment & financial assistance to kidney patients | Health Services |
University of Georgia School of Law
 University of Georgia School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
